These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15892860)

  • 1. Interspecies exchange mutagenesis of the first epidermal growth factor-like domain of human factor VII.
    Williamson V; Pyke A; Sridhara S; Kelley RF; Blajchman MA; Clarke BJ
    J Thromb Haemost; 2005 Jun; 3(6):1250-6. PubMed ID: 15892860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
    Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
    J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
    Jin J; Perera L; Stafford D; Pedersen L
    J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex.
    Ndonwi M; Broze G; Bajaj SP
    J Thromb Haemost; 2005 Jan; 3(1):112-8. PubMed ID: 15634274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of a recombinant human factor VII structural analogue alters its affinity of binding to tissue factor.
    Sridhara S; Chaing S; High KA; Blajchman MA; Clarke BJ
    Am J Hematol; 1996 Oct; 53(2):66-71. PubMed ID: 8892729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of EGF1 domain peptide in coagulation factor VII with tissue factor and its implications for the triggering of coagulation.
    Mei H; Hu Y; Wang H; Shi W; Deng J; Guo T
    J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):42-7. PubMed ID: 20155454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a cell line expressing recombinant factor VII and its subsequent conversion to active form FVIIa through hepsin by genetic engineering method.
    Halabian R; Roudkenar MH; Esmaeili NS; Masroori N; Roushandeh AM; Najafabadi AJ
    Vox Sang; 2009 May; 96(4):309-15. PubMed ID: 19175565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation factor VII Gln100 --> Arg. Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant function.
    Kemball-Cook G; Johnson DJ; Takamiya O; Banner DW; McVey JH; Tuddenham EG
    J Biol Chem; 1998 Apr; 273(14):8516-21. PubMed ID: 9525966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of the N-terminal EGF-like domain from human factor VII.
    Muranyi A; Finn BE; Gippert GP; Forsén S; Stenflo J; Drakenberg T
    Biochemistry; 1998 Jul; 37(30):10605-15. PubMed ID: 9692950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.
    Kao YH; Lee GF; Wang Y; Starovasnik MA; Kelley RF; Spellman MW; Lerner L
    Biochemistry; 1999 Jun; 38(22):7097-110. PubMed ID: 10353820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q).
    O'Brien DP; Kemball-Cook G; Hutchinson AM; Martin DM; Johnson DJ; Byfield PG; Takamiya O; Tuddenham EG; McVey JH
    Biochemistry; 1994 Nov; 33(47):14162-9. PubMed ID: 7947828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VII deficiency caused by a structural variant N57D of the first epidermal growth factor domain.
    Leonard BJ; Chen Q; Blajchman MA; Ofosu FA; Sridhara S; Yang D; Clarke BJ
    Blood; 1998 Jan; 91(1):142-8. PubMed ID: 9414278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.
    Thiec F; Cherel G; Christophe OD
    J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired human tissue factor-mediated activity in blood clotting factor VIINagoya (Arg304-->Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor.
    Matsushita T; Kojima T; Emi N; Takahashi I; Saito H
    J Biol Chem; 1994 Mar; 269(10):7355-63. PubMed ID: 8125953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency.
    Branchini A; Ferrarese M; Lombardi S; Mari R; Bernardi F; Pinotti M
    J Thromb Haemost; 2016 Oct; 14(10):1994-2000. PubMed ID: 27513915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s).
    Furlan Freguia C; Toso R; Pollak ES; Arruda VR; Pinotti M; Bernardi F
    Haematologica; 2004 Dec; 89(12):1504-9. PubMed ID: 15590402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitution in factor IX.
    Ndonwi M; Broze GJ; Agah S; Schmidt AE; Bajaj SP
    J Biol Chem; 2007 May; 282(21):15632-44. PubMed ID: 17387172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and fast preparation of biologically active recombinant human coagulation factor VII in CHO-K1 cells.
    Xiao W; Li CQ; Xiao XP; Lin FZ
    Genet Mol Res; 2013 Dec; 12(4):6813-24. PubMed ID: 24391029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two naturally occurring mutations on FVII gene (S363I-W364C) altering intrinsic catalytic activity.
    Peyvandi F; De Cristofaro R; Akhavan S; Carew JA; Landolfi R; Bauer KA; Mannucci PM
    Thromb Haemost; 2002 Nov; 88(5):750-5. PubMed ID: 12428089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation factor VII variants resistant to inhibitory antibodies.
    Branchini A; Baroni M; Pfeiffer C; Batorova A; Giansily-Blaizot M; Schved JF; Mariani G; Bernardi F; Pinotti M
    Thromb Haemost; 2014 Nov; 112(5):972-80. PubMed ID: 25104096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.